J&J joins Bristol Myers Squibb with $100M commitment to diversity efforts
A day after the Bristol Myers Squibb Foundation launched a $100 million program to diversify clinical trials, Johnson & Johnson says it’s also committing $100 million to health equity efforts.
“There is an urgent need to take on the inequities rooted in systemic racism that threaten health in communities of color across the United States,” CEO Alex Gorsky said in a statement. “That’s why Johnson & Johnson is focusing its efforts and committing $100 million to address racial and social injustice as the critical public health issue that it is.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.